Safety and Efficacy of Prophylactic Topical Steroid Administration for Enfortumab Vedotin–related Cutaneous Toxicity

Enfortumab vedotin (EV) is used to treat unresectable/metastatic urothelial carcinoma but often causes cutaneous toxicity (EVRCT) because of Nectin4 expression in the skin, which reduces patients’ quality of life and can lead to dose adjustments or discontinuation. We explored whether applying topic...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yuki Kita, Takashi Nomura, Saeko Nakajima, Satoru Yonekura, Kaoru Murakami, Takayuki Sumiyoshi, Kimihiko Masui, Takayuki Goto, Ryoichi Saito, Kenji Kabashima, Takashi Kobayashi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2024-12-01
coleção:	European Urology Open Science
Assuntos:	Enfortumab vedotin Cutaneous toxicity Prophylactic topical steroid
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2666168324010863
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!